✦ LIBER ✦

Safety Profile of Pharmacokinetically Targeted Intravenous Busulfan Combined with Fludarabine (BuFlu) as Conditioning Prior to Allogeneic Peripheral Blood Hematopoietic Cell Transplant

✍ Scribed by J. Perkins; M. Alsina; E. Ayala; K. Fancher; H. Fernandez; M. Kharfan-Dabaja; L. Ochoa-Bayona; L. Perez; J. Raychaudhuri; D. Sullivan; C. Tate; T. Field

Book ID: 116280830
Publisher: Elsevier Science
Year: 2009
Tongue: English
Weight: 62 KB
Volume: 15
Category: Article
ISSN: 1083-8791
DOI: 10.1016/j.bbmt.2008.12.329

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Low treatment related mortality and impr

Low treatment related mortality and improved survival in allogeneic peripheral blood stem cell transplant: Targeted intravenous Busulfan combined with Fludarabine (tBuFlu) as conditioning regimen

✍ T.L. Field; J. Perkins; M. Alsina; E. Ayala; K. Fancher; W. Janssen; L. Perez; D 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 68 KB

Maximally Tolerated Busulfan Area Under

Maximally Tolerated Busulfan Area Under the Concentration-Time Curve (AUC) in Combination With Fludarabine as Conditioning Prior to Allogeneic Hematopoietic Cell Transplantation

✍ J. Perkins; T. Fields; J. Kim; H. Fernandez; L. Perez; E. Ayala; M. Kharfan-Daba 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 51 KB

Phase 2 study of targeted intravenous bu

Phase 2 study of targeted intravenous busulfan (IV BU) combined with fractionated total body irradiation (FTBI) and etoposide (VP-16) as preparative regimen for allogeneic peripheral blood stem cell transplant (PBSCT) for patients with poor risk leukemia

✍ A.S. Stein; M.R. O’Donnell; A. Dagis; A. Krishnan; A. Nademanee; R. Nakamura; P. 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 58 KB